ONCY Oncolytics Biotech Inc.
$0.75▼ -3.43%
Healthcare
Other
After hours
$0.75▲ +0.60%
Sep 11, 7:36 PM ET
Volume 1.20M
Avg Volume (10D) 1.04M
Key Metrics & Fundamentals
Market Cap
$95.06M
P/E Ratio
–
Div Yield
–%
52W Range
0.73 - 1.51
% vs 50 MA
-10.39%
% vs 200 MA
-19.77%
RSI-14
34.2
MACD Histogram
-0.0100
Beta (1Y vs SPY)
1.66
Free Cash Flow
-$8.14M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$9.37M
COGS
–
Operating Exp
$9.38M
Operating Income
-$9.38M
EBIT
-$9.38M
Pretax Income
-$9.34M
Net Income
-$9.44M
EPS (Diluted)
-0.08
Price & Volume History
Loading chart…
Recent News
Oncolytics Biotech® Announces Positive Preclinical Results Combining Pelareorep with a Pan-RAS Inhibitor in Colorectal Cancer
GlobeNewswire · Sep 10, 2026 12:15 PM
3 Small Cap Biotech Stocks Trading At A Discount With Late Stage Clinical Catalysts
Simply Wall St. · Aug 28, 2026 4:44 AM
ONCY: FDA Provides Alignment on Registrational Pathway for Pelareorep in CRC
Zacks Small Cap Research · Aug 27, 2026 10:10 AM
Why Oncolytics Biotech Just Cleared A Hurdle That Stalls Most Cancer Trials
Simply Wall St. · Aug 19, 2026 6:15 AM
Oncolytics Biotech® Aligns with FDA on Registrational Path for Second-Line RAS-Mutant MSS Colorectal Cancer
GlobeNewswire · Aug 18, 2026 1:00 PM
Oncolytics Biotech Gets US FDA Fast Track Designation for Pelareorep Combination in Anal Cancer Treatment
MT Newswires · Jul 20, 2026 1:48 PM
Oncolytics Biotech® Receives Fast Track Designation for Pelareorep in Second-Line and Later Anal Cancer
GlobeNewswire · Jul 20, 2026 1:00 PM
ONCY: Seeking Registration Pathway for Part B of REO 033 Trial
Zacks Small Cap Research · Jul 16, 2026 11:16 AM
Oncolytics Biotech Shares Climb Ahead of Planned FDA Meeting on REO 033 Trial (ONCY)
InvestorsHub · Jul 13, 2026 2:13 PM
Oncolytics Biotech® Reports FDA Regulatory Milestone and Strong Clinical Progress in Randomized RAS-Mutant MSS Colorectal Cancer Trial
GlobeNewswire · Jul 13, 2026 1:00 PM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See ONCY's money flow as a full page
Social Sentiment
No Reddit posts found for ONCY.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.